title: Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses.
abstract: Recent success in pancreatic islet allotransplantation has raised expectations but has equally highlighted the acute shortage of donor tissue. The use of xenogeneic tissue would help to address this shortage; however, strong cellular immunity limits the application of this approach. T-cell responses to xenogeneic tissues involve recognition of intact species-mismatched major histocompatibility complex (MHC) molecules, the direct pathway, and xenogeneic proteins presented as peptides by responder-type MHC molecules, the indirect pathway. In this study, we exploited the species difference to selectively and sequentially inhibit direct and indirect xenoresponses after transplantation of porcine islets into mice. Selective inhibition of the direct response was achieved using porcine CTLA4-Ig, which binds preferentially to pig versus mouse B7 molecules. Selective inhibition of the indirect response was achieved using murine CTLA4-Ig, which binds preferentially to mouse B7 molecules. Administration of porcine CTLA4-Ig alone caused modest prolongation of islet survival. Injection of murine CTLA4-Ig alone had a minimal effect. However, the injection of the porcine fusion protein early and the murine homolog late after grafting led to permanent survival of the porcine islets, in the absence of any other immunosuppression. These results suggest that a similar approach could have clinical utility in porcine islet xenotransplantation.
authors.affiliation: Department of Immunology, Division of Medicine, Imperial College London, UK.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Mirenda
authors.forename: Dela
authors.initials: D
authors.lastname: Golshayan
authors.forename: Joseph
authors.initials: J
authors.lastname: Read
authors.forename: Ivan
authors.initials: I
authors.lastname: Berton
authors.forename: Anthony N
authors.initials: AN
authors.lastname: Warrens
authors.forename: Anthony
authors.initials: A
authors.lastname: Dorling
authors.forename: Robert I
authors.initials: RI
authors.lastname: Lechler
mesh_terms: D000069594:Abatacept; D000818:Animals; D000937:Antigen-Antibody Reactions; D005802:Genes, MHC Class II / Q000235:genetics / Q000276:immunology; D006084:Graft Rejection / Q000517:prevention & control*; D018796:Immunoconjugates / Q000276:immunology; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D013552:Swine; D013601:T-Lymphocytes / Q000276:immunology*; D014183:Transplantation, Heterologous
chemical_list: D018796:Immunoconjugates; D000069594:Abatacept